The ILLUMINA Study. (ILLUMINA) (ILLUMINA)
Innovative siroLimus seLf Expanding drUg-eluting Stent for the treatMent of perIpheral Disease: Evaluation of Safety aNd efficAcy. The ILLUMINA Study. (ILLUMINA)
Sponsor: CID - Carbostent & Implantable Devices
A NA clinical study on Peripheral Arterial Disease, this trial is completed. The trial is conducted by CID - Carbostent & Implantable Devices and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
May 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — May 2020 [monthly]
Active Not Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CID - Carbostent & Implantable Devices
For direct contact, visit the study record on ClinicalTrials.gov .